Researchers discover blood markers that could predict mesothelioma treatment success
By Richard Schoonraad | Bioimaging Research and Innovation for Translational Engingeering BRITE, Cancer, Cancer Epigenetics, Cancer Program, Cell Signalling, Lab, Mesothelioma, News & Events, ResearchA groundbreaking study by researchers at the National Centre for Asbestos Related Diseases (NCARD), The Kids Research Institute and the Harry Perkins Institute of Medical Research (the Perkins) has identified…
Perkins researcher awarded Raine Priming Grant
By Alicia Bienkowski | Lab, Media Releases, News & Events, ResearchDr Mridul Johari from the Perkins Rare Disease Genetics and Functional Genomics Group has been awarded a prestigious Raine Priming Grant from the Raine Medical Research Foundation. Dr Johari’s project,…
WA’s Brightest Minds Recognised through the 2024 Aspire Awards
By Alicia Bienkowski | Funding, Media Releases, News & Events, ResearchAssociate Professor Elena Juan Pardo, a researcher at the Harry Perkins Institute of Medical Research, is among ten Western Australian recipients of the Business Events Perth 2024 Aspire Awards. The…
Perth gains NATA-accreditation for rare disease diagnostic tool
By Richard Schoonraad | Disease Area, Epigenetics and Genomics Laboratory, Genetic Disease, Genetic Neuromuscular Disorders, Genetics, Media Releases, Muscles, Muscular Dystrophy, News & Events, Research, Research AreaResearchers at Perth’s Harry Perkins Institute of Medical Research and PathWest Laboratory Medicine WA are celebrating the long-awaited nationally recognised accreditation of a world-leading diagnostic technology that will provide faster,…
Federal funding helps WA Biotech firm save lives
By Alicia Bienkowski | Disease Area, Funding, Lab, Media Releases, News & Events, Research, Research AreaCytophenix, a WA biotech startup led by Perkins Researcher Dr Kieran Mulroney, has been awarded a $500,000 grant as part of the Brandon BioCatalyst’s CUREator Incubator’s Health Security funding stream. …
Lowering cancer drug dose could open tumours to immunotherapy
By Alicia Bienkowski | Brain, Cancer, Cancer, Disease Area, Lab, Media Releases, Melanoma Discovery, Melonoma, News & Events, Research, Research Area, Systems Biology and GenomicsGroundbreaking research undertaken at the Harry Perkins Institute of Medical Research in Perth has shown that administering anti-cancer drugs at a hundred-fold lower dose than standard protocols could improve the…
Genetic Variants Linked to Severe Form of Muscular Dystrophy
By Alicia Bienkowski | Development of Improved Diagnostics for Genetic Disease, Development of Therapies for Selected Genetic Muscle Diseases, Genetic Disease, Genetic Disease, Genetic Neuromuscular Disorders, Genetics, Lab, Muscular Dystrophy, News & Events, Rare Disease Genetics and Functional Genomics, ResearchResearchers from Perth’s Harry Perkins Institute of Medical Research have led a study that uncovered changes in a gene associated with a rare and severe form of muscular dystrophy. The…
Gene Mutation Discovery Sheds Light on Rare Muscle Disorder
By Alicia Bienkowski | Development of Improved Diagnostics for Genetic Disease, Development of Therapies for Selected Genetic Muscle Diseases, Genetic Disease, Genetic Disease, Genetic Neuromuscular Disorders, Genetics, Lab, Muscular Dystrophy, News & Events, Rare Disease Genetics and Functional Genomics, ResearchA groundbreaking study led by Dr Mridul Johari and Associate Professor Gina Ravenscroft, has identified that a genetic mutation is responsible for a rare and debilitating form of congenital myopathy.…